Skip to main content
Swing Capital

NGL Fine Chem Ltd

NSE: NGLFINE BSE: 524774

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

₹2,251
52W: ₹980 — ₹2768
PE 46.7 · Book ₹476 · +373% vs book
Market Cap₹1,391 Cr
Stock P/E46.7Price to Earnings
ROCE8.29%Return on Capital
ROE6.68%Return on Equity
Div. Yield0.07%Face Value ₹5

Strengths

  • +Company is expected to give good quarter

Weaknesses

  • −Stock is trading at 4.69 times its book value
  • −Company has a low return on equity of 10.5% over last 3 years.
  • −Dividend payout has been low at 4.72% of profits over last 3 years

Shareholding Pattern

Promoters72.73%
FIIs0.03%
DIIs0%
Public27.23%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters72.74%72.74%72.74%72.74%72.74%72.74%72.74%72.73%▼0.0
FIIs0.03%0.02%▼0.00.05%▲0.00%▼0.10%0%0%0.03%▲0.0
DIIs0%0%0%0%0%0%0%0%
Public27.24%27.25%▲0.027.23%▼0.027.26%▲0.027.26%27.26%27.26%27.23%▼0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales79859688918793101117126
Expenses6674838281838993103106
Operating Profit1311136114481420
OPM %17%13%13%7%12%4%4%8%12%16%
Net Profit119118101-18815
EPS ₹17.7614.4117.5612.6716.251.26-0.8412.3712.7923.86

AI Insights

Revenue Trend

TTM revenue at ₹437Cr, up 21.7% YoY. OPM at 10%.

Debt Position

Borrowings at ₹87Cr. Debt-to-equity ratio: 0.30x. Healthy balance sheet.

Capex Cycle

CWIP at ₹35Cr (24% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 0% (-0.01pp change). FIIs: 0.03% (+0.03pp change). Promoters hold 72.73%.

Margin & Efficiency

ROCE declining from 24% (Mar 2014) to 8% (Mar 2025). Working capital days: 51.

Valuation

PE 46.7x with 8.29% ROCE. Price is 373% above book value of ₹476. Dividend yield: 0.07%.

Recent Announcements